Pediatrix Medical Group/$MD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pediatrix Medical Group
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Ticker
$MD
Sector
Primary listing
NYSE
Employees
4,120
Headquarters
Website
MD Metrics
BasicAdvanced
$1.4B
12.86
$1.29
1.21
-
Price and volume
Market cap
$1.4B
Beta
1.21
52-week high
$17.67
52-week low
$10.39
Average daily volume
883K
Financial strength
Current ratio
2.021
Quick ratio
1.744
Long term debt to equity
73.622
Total debt to equity
77.908
Interest coverage (TTM)
5.59%
Profitability
EBITDA (TTM)
236.725
Gross margin (TTM)
24.36%
Net profit margin (TTM)
5.66%
Operating margin (TTM)
10.97%
Effective tax rate (TTM)
22.39%
Revenue per employee (TTM)
$470,000
Management effectiveness
Return on assets (TTM)
6.50%
Return on equity (TTM)
14.27%
Valuation
Price to earnings (TTM)
12.86
Price to revenue (TTM)
0.721
Price to book
1.7
Price to tangible book (TTM)
-3.39
Price to free cash flow (TTM)
6.167
Free cash flow yield (TTM)
16.22%
Free cash flow per share (TTM)
2.698
Growth
Revenue change (TTM)
-3.08%
Earnings per share change (TTM)
-142.49%
3-year revenue growth (CAGR)
-0.32%
10-year revenue growth (CAGR)
-2.86%
3-year earnings per share growth (CAGR)
9.81%
10-year earnings per share growth (CAGR)
-9.17%
What the Analysts think about MD
Analyst ratings (Buy, Hold, Sell) for Pediatrix Medical Group stock.
Bulls say / Bears say
Pediatrix posted Q2 adjusted EPS of $0.53, beating consensus by 25% and driving a 6.0% increase in NICU days, leading management to raise its full-year adjusted EBITDA outlook to $245–$255 million (Investing.com).
In Q1 2025, Pediatrix reported net revenue of $458 million and grew adjusted EPS to $0.33 from $0.20 year-over-year, with $49 million in adjusted EBITDA, prompting management to increase its full-year 2025 EBITDA outlook (Business Wire).
By March 31, 2025, Pediatrix reduced net debt to $612.6 million from $617.7 million at year-end 2024 and improved Q1 cash flow use to $116.1 million from $122.6 million a year earlier, demonstrating increased balance sheet efficiency (Nasdaq).
Pediatrix’s Q2 revenue was $468.8 million, down 7.0% year-over-year, mainly due to practice dispositions which offset growth in same-unit revenue (Investing.com).
Cash and cash equivalents dropped to $99.0 million by Q1 2025 from $229.9 million at the end of 2024, reflecting significant seasonal cash outflows for incentive compensation and benefit payments (Nasdaq).
With just $1.3 million left under its $500 million share repurchase program as of March 31, 2025, Pediatrix has little capacity for further capital returns, which could weaken support for shareholder value (Nasdaq).
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2025.
MD Financial Performance
Revenues and expenses
MD Earnings Performance
Company profitability
MD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pediatrix Medical Group stock?
Pediatrix Medical Group (MD) has a market cap of $1.4B as of September 15, 2025.
What is the P/E ratio for Pediatrix Medical Group stock?
The price to earnings (P/E) ratio for Pediatrix Medical Group (MD) stock is 12.86 as of September 15, 2025.
Does Pediatrix Medical Group stock pay dividends?
No, Pediatrix Medical Group (MD) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Pediatrix Medical Group dividend payment date?
Pediatrix Medical Group (MD) stock does not pay dividends to its shareholders.
What is the beta indicator for Pediatrix Medical Group?
Pediatrix Medical Group (MD) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.